XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Intangible assets and goodwill
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible assets and goodwill

12.        Intangible assets and goodwill

Definite-lived intangibles

Definite-lived intangible assets consisted of the following at March 31, 2025 and December 31, 2024:

Ending Balance at

Foreign

Ending Balance at

Definite-lived

December 31,

currency

March 31,

intangibles assets, gross

    

2024

    

Additions

    

translation

2025

Waylivra

12,397

1,791

495

14,683

Tegsedi

18,249

878

726

19,853

Kebilidi

10,731

10,731

Upstaza

106,937

106,937

Total definite-lived intangibles, gross

$

148,314

$

2,669

$

1,221

$

152,204

Ending Balance at

Foreign

Ending Balance at

Definite-lived

December 31,

currency

March 31,

intangibles assets, accumulated amortization

    

2024

    

Amortization

    

translation

    

2025

Waylivra

(5,273)

(540)

(212)

(6,025)

Tegsedi

(5,609)

(806)

(226)

(6,641)

Kebilidi

(112)

(224)

(336)

Upstaza

(18,526)

(2,228)

(20,754)

Total definite-lived intangibles, accumulated amortization

$

(29,520)

$

(3,798)

$

(438)

$

(33,756)

Total definite-lived intangibles, net

$

118,448

Akcea is entitled to receive royalty payments subject to certain terms set forth in the Tegsedi-Waylivra Agreement related to sales of Waylivra and Tegsedi. In accordance with the guidance for an asset acquisition, the Company records royalty payments when they become payable to Akcea and increase the cost basis for the Waylivra and Tegsedi intangible assets. For the three months ended March 31, 2025, royalty payments of $0.9 million and $1.8 million were recorded for Tegsedi and Waylivra, respectively. As of March 31, 2025, a royalty payable of $0.7 million and $1.6 million for Tegsedi and Waylivra, respectively, was recorded on the consolidated balance sheet within accounts payable and accrued expenses.

For the three months ended March 31, 2025 and 2024, the Company recognized amortization expense of $3.8 million and $51.5 million, respectively, related to the Emflaza rights, Upstaza/ Kebilidi, Waylivra, and Tegsedi intangible assets. The estimated future amortization of the Upstaza/Kebilidi, Waylivra, and Tegsedi intangible assets is expected to be as follows:

    

As of March 31, 2025

2025

$

11,370

2026

 

15,162

2027

 

15,162

2028

 

15,162

2029 and thereafter

 

61,592

Total

$

118,448

The weighted average remaining amortization period of the definite-lived intangibles as of March 31, 2025 is 8.9 years.

Goodwill

As a result of the Agilis Merger on August 23, 2018, the Company recorded $82.3 million of goodwill. As of March 31, 2025, there have been no changes to the balance of goodwill since the date of the Agilis Merger. Accordingly, the goodwill balance as of March 31, 2025 is $82.3 million.